RAISE: Open Science and Open Innovation Platforms in Pharmaceutical Companies
Join us for an enlightening panel discussion where industry leaders will address crucial questions about Open Innovation programs at pharmaceutical companies.
This informative conversation will explore pivotal questions such as how these programs drive breakthrough advancements in medicine, strategies for successful faculty collaboration with industry, and the impact of open innovation on patient outcomes.
Whether you're a faculty member curious about how to integrate your research with pharmaceutical innovation or passionate about the future of medicine, this discussion promises to foster meaningful dialogue and useful takeaways.
Don’t miss this opportunity to gain valuable insights into the strategic, financial, and operational aspects of Open Innovation programs and to connect with thought leaders who are shaping the future of pharmaceutical innovation.
Panel discussion 5:00-6:00 PM
Networking session 6:00-7:00 PM
Hors d'oeuvres and beverages served.
PANELISTS:
Co-Moderator: Anjelica Gonzalez, PhD, Professor of Biomedical Engineering, Yale School of Medicine
Pharma Panelist: Maureen Doyle-Scharff, PhD, Group Lead for Global Medical Grants and Partnerships at Pfizer; Executive Director, Institute of Translational Equitable Medicine
Pharma Panelist: Pam Hill, MS, Senior Director, Head of Open Innovation Program at AstraZeneca
Pharma Panelist: Danilo Casimiro, PhD, Chief Science Officer & Global Head, External Scientific Affairs, Sanofi Vaccines R&D
Pharma Panelist: Christine Ivashchenko, PhD, Director of Scientific Projects at Novo Nordisk BioInnovation Hub
Pharma Panelist: Gaylene Anderson, MBA, Director, Strategic Research Relationships, Discovery Research Coordination, at Boehringer Ingelheim Pharmaceuticals, Inc.
PARKING OPTIONS:
Temple Street Garage: Open 24 Hours
Street parking - as available - near 101 College Street